Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1
Minnie Sarwal(Stanford University), Oscar Salvatierra(Stanford University), Maria T. Millan(Stanford University), Thomas Satterwhite(Align Technology (United States)), Jayakumar R. Vidhun(Stanford University), Steven R. Alexander(Stanford University)
Cited by 223
Related Papers
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
|New England Journal of Medicine|2003|697
Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry
|American Journal of Kidney Diseases|2009|690
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
|Science Translational Medicine|2011|621